1,202
Views
0
CrossRef citations to date
0
Altmetric
Drug profile

Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia

Pages 211-221 | Received 05 Jan 2024, Accepted 08 May 2024, Published online: 21 May 2024